Free Access
Issue |
Med Sci (Paris)
Volume 33, Number 5, Mai 2017
|
|
---|---|---|
Page(s) | 463 - 465 | |
Section | Nouvelles | |
DOI | https://doi.org/10.1051/medsci/20173305002 | |
Published online | 14 June 2017 |
- Piel FB, Patil AP, Howes RE, et al. Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates. Lancet 2013 ; 381 : 142–151. [CrossRef] [PubMed] [Google Scholar]
- Ware RE, de Montalembert M, Tshilolo L, Abboud MR. Sickle cell disease. Lancet 2017. Jan 31. pii: S0140–6736(17)30193–9. doi: 10.1016/S0140-6736(17)30193-9. [Google Scholar]
- Ngo S, Bartolucci P, Lobo D, et al. Causes of death in sickle cell disease adult patients: old and new trends. ASH 56th annual meeting. Blood 2014 ; 124 : 2715. [Google Scholar]
- Gluckman E, Cappelli B, Bernaudin F, et al. Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation. Blood 2017 ; 129 : 1548–1556. [Google Scholar]
- Angelucci E, Matthes-Martin S, Baronciani D, et al. Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel. Haematologica 2014 ; 99 : 811–820. [CrossRef] [PubMed] [Google Scholar]
- Cavazzana-Calvo M, Payen E, Negre O, et al. Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia. Nature 2010 ; 467 : 318–322. [CrossRef] [PubMed] [Google Scholar]
- Cavazzana-Calvo M, Hacein-Bey-Abina S, Fischer A. Dix ans de thérapie génique : réflexions. Med Sci (Paris) 2010 ; 26 : 115–118. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- Ribeil JA, Hacein-Bey-Abina S, Payen E, et al. Gene therapy in a patient with sickle cell disease. N Engl J Med 2017 ; 376 : 848–855. [Google Scholar]
- Coulombel L. Le transgène anti-falciformation. Med Sci (Paris) 2002 ; 18 : 155–165. [EDP Sciences] [Google Scholar]
- Negre O, Bartholomae C, Beuzard Y, et al. Preclinical evaluation of efficacy and safety of an improved lentiviral vector for the treatment of β-thalassemia and sickle cell disease. Curr Gene Ther 2015 ; 15 : 64–81. [CrossRef] [PubMed] [Google Scholar]
- Rossi A, Salvetti A. Intégration des vecteurs AAV et mutagenèse insertionnelle. Med Sci (Paris) 2016 ; 32 : 167–174. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.